AUTUMN WILLIAMS: Open Payments
NPI 1619438413 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 16 payments from 13 companies in 2025. Trend: 2023 $1,895 · 2024 $702 · 2025 $1,661
Food & beverage: $1,561Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $275 |
| AstraZeneca Pharmaceuticals LP | 2 | $246 |
| E.R. Squibb & Sons, L.L.C. | 2 | $229 |
| JAZZ PHARMACEUTICALS INC. | 1 | $132 |
| Kite Pharma, Inc. | 1 | $129 |
| ABBVIE INC. | 1 | $123 |
| Novocure Inc. | 1 | $123 |
| Deciphera Pharmaceuticals Inc. | 1 | $115 |
| Alnylam Pharmaceuticals Inc. | 1 | $114 |
| Astellas Pharma US Inc | 1 | $100 |
Products named: UPLIZNA, ZEPZELCA, Yescarta, CALQUENCE, RINVOQ, Optune Lua (NovoTTF-200T), OPDIVO, ROMVIMZA.
Industry payments across NC — which companies pay providers there.
